annual meeting program - American Society of Clinical Oncology

SUNDAY
Sunday, June 6, 2010
8:00 AM - 12:00 PM
GENERAL POSTER SESSION
Head and Neck Cancer
Location: S Hall A2
Tracks(s): Head and Neck Cancer
Brd. 10A Tumor molecular correlates of unresectable, locally advanced head and neck
squamous cell carcinoma (SCCHN) response to concurrent radiation (RT),
cisplatin (DDP), and cetuximab (C225) in a phase II trial (ECOG 3303).
(Abstract #5537)
A. M. Egloff, J. Lee, A. E. Vaezi, C. J. Langer, A. A. Forastiere, H. Quon,
B. Burtness, J. R. Grandis, Department of Pathology, University of Pittsburgh
Brd. 10B Evaluation of the incidence and prognostic value of mutant epidermal growth
factor receptor (EGFRvIII) protein expression in head and neck squamous
cell carcinomas (HNSCC) using AQUA. (Abstract #5538)
E. Pectasides, G. Fountzilas, P. Kountourakis, P. Gouveris, C. Sasaki, D. Duffey,
D. Rimm, B. Burtness, D. Psyrri
Brd. 10C Analysis of ERCC1 (excision repair cross complementing group 1) in
squamous cell carcinoma of the head and neck (SCCHN) by quantitative
immunohistochemistry (IHC) using FL297. (Abstract #5539)
R. Mehra, K. Q. Cai, F. Zhu, J. Weaver, N. Nicolaou, R. B. Cohen, M. Lango,
J. A. Ridge, A. K. Godwin, B. Burtness
Brd. 10D ERCC1 protein, mRNA expression, and T19007C polymorphism as
prognostic markers in head and neck squamous cell carcinoma (HNSCC)
patients treated with surgery and adjuvant cisplatin-based chemoradiation
(CRT). (Abstract #5540)
G. Castro, F. S. Pasini, S. A. Siqueira, A. R. Ferraz, R. C. Villar, I. M. Snitcovsky,
M. H. Federico
Brd. 10E Expression and prognostic significance of X-ray crosscomplementation
group 1 (XRCC1) in head and neck squamous cell carcinoma patients
undergoing concurrent chemoradiation. (Abstract #5541)
M. Ang, N. Zhao, M. Hayward, M. Patel, X. Yin, M. D. Wilkerson, W. K. Funkhouser
Jr., K. Fritchie, A. Olshan, D. N. Hayes
Brd. 10F Use of angiopoietin-1 expression in squamous cell carcinoma of the head
and neck to predict disease-free survival. (Abstract #5542)
M. Dhiwakar, J. P. Malone, P. A. Kay, K. T. Robbins, S. Ran
Brd. 10G Correlation of expression of haptoglobin and recurrence in head and neck
squamous cell cancer. (Abstract #5543)
Y. Su, C. Lee, S. Hong, H. Lin, S. Li, C. Yu, Y. Tung
Brd. 10H Outcomes in HPV-associated oropharyngeal squamous cell carcinoma after
postoperative or definitive nonsurgical therapy. (Abstract #5544)
C. R. Spencer, H. Gay, B. H. Haughey, B. Nussenbaum, D. Adkins,
D. I. Kuperman, I. El Naqa, J. S. Lewis Jr., V. Auethavekiat, W. L. Thorstad
Brd. 11A Detection of antibodies to the HPV16 proteome in head and neck cancer
patient sera. (Abstract #5545)
K. S. Anderson, J. Wong, M. R. Posner, A. B. Riemer, J. H. Lorch, R. I. Haddad,
J. Bryan, M. Mclean, K. Kelsey
Brd. 11B Prognosis of HPV-positive squamous cell carcinoma of tonsil-expressing
high level of p16 and low level of EGFR. (Abstract #5546)
H. Won, D. Sun, S. Chun, E. Jeon, M. Chang, C. Jung, B. Shim, M. Lee, J. Kang,
J. Kim
Brd. 11F Use of T-cell infiltrate to predict long-term survival following local therapy in
tongue cancer patients. (Abstract #5547)
J. Kim, S. Kim, J. Choi, B. Shin, S. Yoon, J. Seo, S. W. Shin, Y. H. Kim, J. S. Kim,
K. Park
202